Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014

Size: px
Start display at page:

Download "Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014"

Transcription

1 Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014 The Pew Charitable Trusts is an independent, nonprofit organization focused on implementing evidence-based policies to solve today s most challenging problems. Pew has been involved in the issue of antibiotic resistance for almost a decade, with efforts focused on implementing policies in the United States to address the urgent need for new antibiotics and the widespread inappropriate use of antibiotics in animal agriculture. We appreciate the opportunity to submit comments on the World Health Organization s draft global action plan to address antimicrobial resistance. Key Areas of Concern ( From the perspective of your organization, what are the most important areas of concern in AMR? ) Antimicrobial resistance, in particular bacterial resistance, poses a grave threat to global health and necessitates broad, multifaceted solutions. Pew focuses on three main areas: Incentivizing the Development of New Antibiotics and other Novel Therapies Ending the Overuse of Antibiotics in Food Animals Ensuring the Appropriate Use of Antibiotics across Healthcare Settings Incentivizing the Development of New Antibiotics and other Novel Therapies As the U.S. Centers for Disease Control and Prevention (CDC) identified in its 2013 threat assessment, antibiotic development is a critical component of any strategy to address antimicrobial resistance. 1 New antibiotics with novel mechanisms of action will always be needed, as the development of resistance to existing drugs inevitably develops. Antibiotic drug development has been in decline for decades, and the number of new drugs in the pipeline is alarmingly low. Pew analysis of the U.S. pipeline found 43 new antibiotics currently in clinical development as of June 2014; 2 however, given that, on average, no more than one in five drugs that make it to the initial phase of clinical trials receive U.S. Food and Drug Administration (FDA) approval, it is clear that there are too few drugs in development to meet current and anticipated patient needs. Moreover, many of the drugs currently in development represent known classes of antibiotics, and only a handful of therapies in early development target bacteria in a completely new way. Economic, regulatory, and scientific challenges all pose obstacles to antibiotic drug development. It is essential that governments and other stakeholders pursue policies to 1 Centers for Disease Control and Prevention, Antibiotic Resistance Threats to the United States, 2013, 2 The Pew Charitable Trusts, Antibiotics Currently in Clinical Development, June 30, 2014,

2 encourage the development of antibiotics and ensure an adequately stocked pipeline that addresses current and anticipated patient needs. Ending the Overuse of Antibiotics in Food Animals Over 45 years of independent, peer-reviewed scientific studies have found a clear association between antibiotic consumption (in both people and food animals) and bacterial resistance. Additionally, the emergence of specific strains of antibiotic resistant bacteria in animals has been associated with the use of specific antibiotics. In some cases, those same strains have infected humans. The injudicious use of antibiotics in food animals presents a serious and growing threat to human health as the practice creates new strains of antibiotic-resistant bacteria. Drug companies, food producers, and veterinarians must take responsibility and assist in reduction efforts. Ensuring the Appropriate Use of Antibiotics across Healthcare Settings Appropriate antibiotic use across healthcare settings is needed to both slow the spread of resistance and protect individual patients from adverse effects associated with antibiotic use, such as Clostridium difficile infections and allergic reactions. In the United States, the CDC estimates that up to 50 percent of antibiotic use is either unnecessary or inappropriate. To curb inappropriate use in hospitals and outpatient settings, a broad range of stakeholders, including governments, public health experts, physicians and leaders of healthcare systems, must work together to implement evidence-based antibiotic stewardship programs. Current Work ( Is your organization currently involved in work related to AMR? If yes, how? ) Pew s work on antibiotic resistance began in 2008, when the Pew Commission on Industrial Farm Animal Production recommended, among other things, that the U.S. completely phase out the nontherapeutic use of antibiotics in food animals. Pew has worked to advance legislative, regulatory, and market-based solutions and to build public and policymaker awareness. Specifically, we supported the development of new the U.S. Food and Drug Administration (FDA) guidelines, issued December 2013, that will remove growth promotion in animals as an approved use for antibiotics. We have also collaborated with public health and consumer groups to bring about regulatory and policy changes on data collection and veterinary oversight of antibiotics. In addition, we have built public awareness of animal-use issues and have influenced institutional purchasing by universities, school districts and hospitals toward poultry and meat raised with responsible use of antibiotics. In support of drug development, Pew was actively involved in developing and advocating for the Generating Antibiotic Incentives Now (GAIN) Act, passed by the U.S. Congress in 2012, which addresses some of the economic challenges facing drug developers by offering an additional five years of market protection for certain antibiotics before they face generic competition. Pew is now working in partnership with congressional champions to support

3 legislation that would create a new limited population mechanism for approval of antibiotics for use in patients who have few other treatment options. In parallel, Pew is working to help identify, prioritize, and develop policy solutions to help address some of the scientific barriers to antibiotic discovery. Increasing awareness and understanding about AMR and of the actions and changes needed (Building Block 1) One key component of driving policy change will be raising the prominence of this issue at the highest levels of government. National strategies to combat antibiotic resistance, including national goals for reduction in antibiotic use in human and animal medicine, can help galvanize attention and resources and drive policy change. To be effective, national goals would require developing consensus among experts and key opinion leaders on the drivers of resistance in each key setting (inpatient, outpatient, and on the farm) and developing a shared understanding of what constitutes reasonable antibiotic use. In addition to developing expert consensus on underlying drivers of overuse and the potential for reductions, if informed by a wide-range of stakeholders, national reduction goals would help ensure that all actors engaged in antimicrobial resistance efforts are aware of the necessary actions and required resources and are better able to coordinate their activities. Additionally, the process of creating and announcing these reduction goals would increase the public s awareness of resistance and a greater understanding of the importance of the issue. Although additional surveillance is needed to ensure accurate assessment of these goals, experts can use currently available data to set and monitor improvement until better systems are in place. Optimizing the use of existing antimicrobials for human and animal health and in agriculture (Building Block 3) Reducing inappropriate antibiotic use in both human healthcare and animal agriculture is critical to slowing the development of resistance and preserving the usefulness of critically needed therapies. In hospital settings, formal antibiotic stewardship programs (ASPs) have been shown to be effective in better coordinating patient care and thereby reducing antibiotic usage. However, in the United States, despite the evidence backing these interventions, many hospitals have yet to implement programs of their own. Thus a key action in this setting is encouraging the adoption of ASPs. Public health authorities can aid in this effort through the provision of technical assistance. In the U.S., for example, the CDC recently released a Vital Signs report detailing key elements for hospitals to include an effective ASP. 3 Policymakers can also directly encourage uptake through state-level or national policies. A California state law requires all hospitals there to establish a process to monitor the 3 U.S. Centers for Disease Control and Prevention, Making Health Care Safer: Antibiotic Rx in Hospitals: Proceed with Caution, Vital Signs, March 2014,

4 judicious use of antibiotics in their facilities. 4 Additionally professional societies such as the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America have called for federal policy efforts in the United States to mandate stewardship programs nationwide. 5 Most antibiotic use in humans, by sales, is in the outpatient setting. Research is needed to understand the contribution of outpatient prescribing to resistance and to develop policies, practices and an evidence base to reduce inappropriate use. Medical professional societies should also be actively engaged in stewardship efforts in these settings. The American Academy of Pediatrics (AAP) has demonstrated the important role these organizations can play in educating their members on antibiotic use and stewardship. Along with eliminating use of antibiotics for growth promotion in food animals, it is essential to develop production systems that do not rely on routine use of antibiotics for disease prevention or create conditions that lead to overuse of these drugs for therapeutic purposes. Achieving this goal will require a concerted effort on the part of agricultural interests, the veterinary community, regulators and policy makers. International efforts to develop standards and share best practices can be an important driver of change. In order to measure movement towards stewardship goals in animals and humans, improved surveillance and data systems are essential. Better data will inform the public and allow for tracking of progress and evaluation of specific interventions. Building Block-4: Identifying and closing critical gaps in knowledge needed to address AMR Adequate surveillance underpins all of the actions necessary to fully address antimicrobial resistance. Currently, many countries lack the ability to not only accurately measure the scope and spread of resistance, but also to measure antibiotic use and assess the impact of different interventions and policies. Improved data collection systems at the national and local levels are needed in order to bolster current efforts and improve interventions in the future. These surveillance systems should monitor all aspects of the problem. Within human health, surveillance systems should ideally monitor rates of resistant infections both in hospitals, as well as the community, in order to accurately describe the burden of resistance. Also important, and more feasible in the short-term, are systems to collect data on antibiotic usage patterns in these different settings to better facilitate stewardship efforts. Policies that encourage increased uptake of surveillance systems to ensure a majority of facilities participate. 4 KK Trivedi and J Rosenberg. The State of Antimicrobial Stewardship Programs in California. Infect Control Hosp Epidemiol. 201; 34(4): Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012; 33(4):

5 An example of the potential for progress around human health surveillance in the U.S. is the CDC s launch of an Antibiotic Use and Resistance (AUR) module as part of the National Healthcare Safety Network (NHSN) surveillance system. The NHSN is already widely used by hospitals and other medical facilities throughout the U.S. to track healthcare-associated infections. The AUR module will allow these facilities to benchmark antibiotic use and resistance in their facilities, and will eventually enable the CDC to conduct national surveillance. However, the number of hospitals currently using the AUR module is low, and additional work must be done to increase uptake. In animal agriculture, there also is a need to measure how antibiotics are being used in the various species of food animals as well as a review of effective alternatives to antibiotic use (vaccines, increased hygiene, probiotics) that exist globally. In Denmark, authorities have enforced limits on antibiotic use in farming by collecting records of veterinary antibiotic use, inspecting farms where problematic overuse is suspected, and issuing warning citations (or yellow cards ) and fines for repeat offenses. Beyond the need for individual countries to improve data collection within their borders, assessment at an international level will require harmonization of surveillance systems. Current systems often vary by population, definitions and methodology. Increased regional and international coordination such as the European Antimicrobial Resistance Surveillance Network (EARS-Net) and the European Surveillance of Antimicrobial Consumption (ESAC-Net) would facilitate assessment of resistance and antibiotic use on a global scale. Building Block-5: Developing an innovative and sustainable approach to develop and distribute critical products and technologies needed to address AMR As noted above, the global pipeline of new antibiotics is inadequate to address emerging and future resistance. Drug makers developed at least 14 new classes of antibiotics between the 1930s and 1960s, 6 but only two new classes of systemic antibiotics since that time. 7 Furthermore, the antibiotics in the pipeline do not address all types of resistant bacteria in the clinic today, leaving gaps in treatment options for many patients with serious infections. Few major pharmaceutical companies remain involved in antibiotic development. Addressing the pipeline requires (1) improving the economic return on antibiotic research and development; (2) ensuring robust but efficient regulatory requirements and development pathways for high-need antibiotics; and (3) addressing scientific gaps that impede drug discovery. 6 JM Conly and BL Johnston. Where are all the new antibiotics? The new antibiotic paradox. Can J Infect Dis Med Microbiol. 2005; 16(3): ARM Coates, G Halls, and Y Hu. Novel classes of antibiotics or more of the same? Br J Pharmacol. 2011; 163(1):

6 The economics of antibiotic development remain daunting. A number of efforts notably, one led by the UK government and ongoing European discussions are evaluating fundamental changes to the current business models for antibiotics developers. Notwithstanding technical challenges, these efforts hold promise. In the near term, efforts to streamline regulatory approval pathways and overcome scientific challenges may be more successful. Regulatory approval for drugs to treat highly resistant bacterial infections is especially challenging because only a small number of patients contract such infections and meet the requirements to participate in traditional clinical trials. As noted above, Pew is supporting the efforts of congressional champions to develop a new regulatory approval pathway in the U.S. for limited-population antibacterial drugs that would address the greatest unmet needs of patients. Pew is also exploring the role that greater collaboration between industry and academic efforts could have in overcoming scientific barriers. Next Steps ( What contribution would your organization be able to make in implementing the global action plan? ) Pew is actively involved in combating antibiotic resistance in the United States, and is well suited to aid in the implementation of a broader global action plan although our work will remain focused on U.S. interventions and policies. Specifically, Pew is able to: Continue awareness raising activities in the United States on the need to incentivize drug development and to optimize the use of antibiotic in human and animal health; Advocate for evidence-based policy solutions in the United States; Review and provide comments on draft action plans; and Organize convenings of relevant stakeholders to further national policies and international coordination.

July 31, The Honorable Michael Bennet U.S. Senate 458 Russell Senate Office Building Washington, DC 20510

July 31, The Honorable Michael Bennet U.S. Senate 458 Russell Senate Office Building Washington, DC 20510 July 31, 2013 The Honorable Michael Bennet U.S. Senate 458 Russell Senate Office Building Washington, DC 20510 The Honorable Orrin Hatch U.S. Senate 104 Hart Senate Office Building Washington, DC 20510

More information

National Action Plan development support tools

National Action Plan development support tools National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan

More information

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics Priority Topic B Diagnostics Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics The overarching goal of this priority topic is to stimulate the design,

More information

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension

More information

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,

More information

Antimicrobial Stewardship: A Public Health Priority

Antimicrobial Stewardship: A Public Health Priority Antimicrobial Stewardship: A Public Health Priority CLSI Workshop June 28, 2014 Kavita K. Trivedi, MD Principal, Trivedi Consults, LLC Adjunct Clinical Assistant Professor of Medicine, Stanford University

More information

Antimicrobial Resistance, yes we care! The European Joint Action

Antimicrobial Resistance, yes we care! The European Joint Action Antimicrobial Resistance, yes we care! The European Joint Action Context of the Joint Action General objectives Inclusive governance Conclusion Context of the Joint Action 1. Context of this Joint Action

More information

Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016

Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016 Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016 What is Antimicrobial Stewardship? Conserving the effectiveness of existing treatments through infection prevention and

More information

8/3/2017 ABX STEWARDSHIP

8/3/2017 ABX STEWARDSHIP ABX STEWARDSHIP 1 Drug resistance follows the drug like a faithful shadow. - Paul Erhlich 1854-1915 2 It is not difficult to make microbes resistant to penicillin in the laboratory by exposing them to

More information

Physician Rating: ( 23 Votes ) Rate This Article:

Physician Rating: ( 23 Votes ) Rate This Article: From Medscape Infectious Diseases Conquering Antibiotic Overuse An Expert Interview With the CDC Laura A. Stokowski, RN, MS Authors and Disclosures Posted: 11/30/2010 Physician Rating: ( 23 Votes ) Rate

More information

Antibiotic Stewardship in Human Health- Progress and Opportunities

Antibiotic Stewardship in Human Health- Progress and Opportunities National Center for Emerging and Zoonotic Infectious Diseases Antibiotic Stewardship in Human Health- Progress and Opportunities CAPT Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship Division

More information

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT 1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved

More information

Canada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017

Canada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017 Canada s Activities in Combatting Antimicrobial Resistance Presentation to the JPIAMR Management Board March 29, 2017 AMR in Canada Surveillance data indicates that rates of infection for some resistant

More information

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial

More information

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Hot Topics in Antimicrobial Stewardship Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Antimicrobial Stewardship Goals Primary Goal Optimize clinical outcomes

More information

Antimicrobial resistance (AMR): action plans implementation. Kamil Saytkulov February, Moscow

Antimicrobial resistance (AMR): action plans implementation. Kamil Saytkulov February, Moscow Antimicrobial resistance (AMR): action plans implementation Kamil Saytkulov 20-21 February, Moscow The Industry Declaration Has been signed by 98 companies and 11 industry associations in 21 countries*

More information

Perspective on AnA Global timicrobial Resistance

Perspective on AnA Global timicrobial Resistance National Center for Emerging and Zoonotic Infectious Diseases Perspective on AnA Global timicrobial Resistance Dawn M. Sievert, PhD, MS Associate Director for Antimicrobial Resistance Division of Foodborne,

More information

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

A Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013

A Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013 A Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013 Participant List Dr. Steve Solomon, Director, Office of Antimicrobial Resistance, Division of Healthcare

More information

Antibiotic Stewardship Beyond Hospital Walls

Antibiotic Stewardship Beyond Hospital Walls Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship

More information

Antimicrobial Stewardship in the Hospital Setting

Antimicrobial Stewardship in the Hospital Setting GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor

More information

ANTIBIOTIC STEWARDSHIP

ANTIBIOTIC STEWARDSHIP ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized

More information

Council of the European Union Brussels, 13 June 2016 (OR. en)

Council of the European Union Brussels, 13 June 2016 (OR. en) Council of the European Union Brussels, 13 June 2016 (OR. en) 9952/16 SAN 241 AGRI 312 VETER 58 NOTE From: To: General Secretariat of the Council Council No. prev. doc.: 9485/16 SAN 220 AGRI 296 VETER

More information

American Veterinary Medical Association

American Veterinary Medical Association A V M A American Veterinary Medical Association 1931 N. Meacham Rd. Suite 100 Schaumburg, IL 60173-4360 phone 847.925.8070 800.248.2862 fax 847.925.1329 www.avma.org March 31, 2010 Centers for Disease

More information

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)] United Nations A/RES/71/3 General Assembly Distr.: General 19 October 2016 Seventy-first session Agenda item 127 Resolution adopted by the General Assembly on 5 October 2016 [without reference to a Main

More information

EU strategy to fight against Antimicrobial Resistance

EU strategy to fight against Antimicrobial Resistance EU strategy to fight against Antimicrobial Resistance OECD workshop on the Economics of Antimicrobial Use in the Livestock Sector and Development of Antimicrobial Resistance Paris, 12 October 2015 Martial

More information

Combating Antimicrobial Resistance: The Way Forward

Combating Antimicrobial Resistance: The Way Forward Combating Antimicrobial Resistance: The Way Forward James M. Hughes, MD Professor of Medicine and Public Health Emory University Atlanta, GA NIAA Antibiotic Symposium November 14, 2014 Disclosure No conflicts

More information

Reinvigorating the Oral Antibacterial Drug Development Pipeline

Reinvigorating the Oral Antibacterial Drug Development Pipeline Reinvigorating the Oral Antibacterial Drug Development Pipeline November 20, 2014 Discussion Guide Introduction Antibacterial drugs are a critical component of the nation s public health armamentarium

More information

Consultation on a draft Global action plan to address antimicrobial resistance

Consultation on a draft Global action plan to address antimicrobial resistance Consultation on a draft Global action plan to address antimicrobial resistance The questionnaire is divided into four sections. The questions are broadly framed and intended to give you the opportunity

More information

Antimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016

Antimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting

More information

Antibiotic Stewardship and Critical Access Hospitals. Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network

Antibiotic Stewardship and Critical Access Hospitals. Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network Antibiotic Stewardship and Critical Access Hospitals Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network Antibiotic-Resistant Bacteria A serious threat to public health and the economy

More information

Strategy 2020 Final Report March 2017

Strategy 2020 Final Report March 2017 Strategy 2020 Final Report March 2017 THE COLLEGE OF VETERINARIANS OF ONTARIO Introduction This document outlines the current strategic platform of the College of Veterinarians of Ontario for the period

More information

Position Statement. Responsible Use of Antibiotics in the Australian Chicken Meat Industry. 22 February What s the Issue?

Position Statement. Responsible Use of Antibiotics in the Australian Chicken Meat Industry. 22 February What s the Issue? 22 February 2018 Position Statement Responsible Use of Antibiotics in the Australian Chicken Meat Industry What s the Issue? Antimicrobial resistance (AMR) The use of antibiotics in both humans and animals

More information

Antimicrobial Resistance: Urgent Need for Responsible and Sustainable R&D Incentives Support HR 6294: REVAMP Act of 2018

Antimicrobial Resistance: Urgent Need for Responsible and Sustainable R&D Incentives Support HR 6294: REVAMP Act of 2018 Antimicrobial Resistance: Urgent Need for Responsible and Sustainable R&D Incentives Support HR 6294: REVAMP Act of 2018 Consensus AMR is a Critical Public Health Threat requiring immediate and significant

More information

The ABCs of Antibiotic Stewardship

The ABCs of Antibiotic Stewardship The ABCs of Antibiotic Stewardship Sarah Brinkman, MBA, MA, CPHQ Program Manager Stratis Health 2018 Flex Program Reverse Site Visit July 18, 2018 Stratis Health Independent, nonprofit, Minnesota-based

More information

Healthcare Facilities and Healthcare Professionals. Public

Healthcare Facilities and Healthcare Professionals. Public Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:

More information

Draft ESVAC Vision and Strategy

Draft ESVAC Vision and Strategy 1 2 3 7 April 2016 EMA/326299/2015 Veterinary Medicines Division 4 5 6 Draft Agreed by the ESVAC network 29 March 2016 Adopted by ESVAC 31 March 2016 Start of public consultation 7 April 2016 End of consultation

More information

Pfizer Position on Antimicrobial Resistance Management. Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017

Pfizer Position on Antimicrobial Resistance Management. Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017 Pfizer Position on Antimicrobial Resistance Management Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017 Objectives and Trends of Nowadays Healthcare Environment Effective and innovative

More information

Improving Human Antibiotic Use in the Community Get Smart: Know When Antibiotics Work

Improving Human Antibiotic Use in the Community Get Smart: Know When Antibiotics Work Improving Human Antibiotic Use in the Community Get Smart: Know When Antibiotics Work Lauri Hicks, DO Director, Office of Antibiotic Stewardship Medical Director, Get Smart: Know When Antibiotics Work

More information

Nursing Home Online Training Sessions Session 2: Exploring Antibiotics and Their Role in Fighting Bacterial Infections

Nursing Home Online Training Sessions Session 2: Exploring Antibiotics and Their Role in Fighting Bacterial Infections National Nursing Home Quality Care Collaborative Nursing Home Online Training Sessions Session 2: Exploring Antibiotics and Their Role in Fighting Bacterial Infections Health Services Advisory Group (HSAG)

More information

RESPONSIBLE ANTIMICROBIAL USE

RESPONSIBLE ANTIMICROBIAL USE RESPONSIBLE ANTIMICROBIAL USE IN THE CANADIAN CHICKEN AND TURKEY SECTORS VERSION 2.0 brought to you by: ANIMAL NUTRITION ASSOCIATION OF CANADA CANADIAN HATCHERY FEDERATION CANADIAN HATCHING EGG PRODUCERS

More information

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Benjamin P. Chan, MD, MPH NH Dept. of Health & Human Services Division of Public Health Services May 23, 2017 To bring a greater

More information

The trinity of infection management: United Kingdom coalition statement

The trinity of infection management: United Kingdom coalition statement * The trinity of infection management: United Kingdom coalition statement This coalition statement, on behalf of our organizations (the UK Sepsis Trust, Royal College of Nursing, Infection Prevention Society,

More information

What is an Antibiotic Stewardship Program?

What is an Antibiotic Stewardship Program? What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent

More information

Developing New Animal Pharma Products Relevance to antibiotic stewardship in animal agriculture. Karin Hoelzer, DVM, Ph.D.

Developing New Animal Pharma Products Relevance to antibiotic stewardship in animal agriculture. Karin Hoelzer, DVM, Ph.D. Developing New Animal Pharma Products Relevance to antibiotic stewardship in animal agriculture Karin Hoelzer, DVM, Ph.D. September 7, 2018 Overview: Structure of today s presentation The role of antibiotic

More information

Appropriate Antimicrobial Use in California: The Path of Least Resistance

Appropriate Antimicrobial Use in California: The Path of Least Resistance Appropriate Antimicrobial Use in California: The Path of Least Resistance BEACON Fall Exchange November 9, 2011 Kavita K. Trivedi, MD Healthcare Associated Infections Program California Department of Public

More information

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Antimicrobial Stewardship-way forward Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Lets save what we have! What is Antibiotic stewardship? Optimal selection, dose and duration of

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION

More information

OBJECTIVES. Fast Facts 3/23/2017. Antibiotic Stewardship Beyond Hospital Walls. Antibiotics are a shared resource and becoming a scarce resource.

OBJECTIVES. Fast Facts 3/23/2017. Antibiotic Stewardship Beyond Hospital Walls. Antibiotics are a shared resource and becoming a scarce resource. Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship

More information

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat EMA Working Parties with Patients and Consumers Organisations (PCWP) and Healthcare Professionals

More information

Minnesota Guide to a Comprehensive. Antimicrobial Stewardship Program

Minnesota Guide to a Comprehensive. Antimicrobial Stewardship Program Minnesota Guide to a Comprehensive Antimicrobial Stewardship Program Getting Started Antimicrobial Stewardship Program Strategies July 2012 Draft 8.10.12 1 Table of Contents Introduction. 3 Getting Started

More information

For Alberta broiler producers, the biggest impacts will be:

For Alberta broiler producers, the biggest impacts will be: Changes to Health Canada s Prescription Drug List: Getting Ready for Changes in Veterinary Oversight Requirements On December 1, 2018 prescription requirements for medically important antimicrobials come

More information

Initiatives for Addressing Antimicrobial Resistance in the Environment. Executive Summary

Initiatives for Addressing Antimicrobial Resistance in the Environment. Executive Summary Initiatives for Addressing Antimicrobial Resistance in the Environment Executive Summary This executive summary highlights key themes from a scientific white paper and discussion at the International Environmental

More information

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN

More information

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance 2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance Submitted by: Merck Sharp & Dohme Policy Forum on Strengthening Surveillance and Laboratory

More information

Antimicrobial Stewardship the State Health Department Perspective

Antimicrobial Stewardship the State Health Department Perspective Antimicrobial Stewardship the State Health Department Perspective Marion A. Kainer MD, MPH, FRACP, FSHEA Healthcare Associated Infections and Antimicrobial Resistance Program NIAA Antibiotic Stewardship:

More information

Raising Awareness for Prudent Use of Antibiotics in Animals

Raising Awareness for Prudent Use of Antibiotics in Animals Raising Awareness for Prudent Use of Antibiotics in Animals Position paper of the global Alliance for the Prudent Use of Antibiotics (APUA) Prepared by Mary Wilson, M.D., and Melanie Tam Presented at WHO

More information

The Core Elements of Antibiotic Stewardship for Nursing Homes

The Core Elements of Antibiotic Stewardship for Nursing Homes The Core Elements of Antibiotic Stewardship for Nursing Homes APPENDIX B: Measures of Antibiotic Prescribing, Use and Outcomes National Center for Emerging and Zoonotic Infectious Diseases Division of

More information

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH Michele Cecchini OECD Health Division Antimicrobial Resistance is a Global Threat Modern medicine and surgery

More information

Objective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest

Objective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial

More information

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!

More information

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU Health and Food Safety John Paget (NIVEL) Dominique Lescure (NIVEL) Ann Versporten (University of Antwerp)

More information

Impact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England

Impact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England Impact of NHS England Quality Indicators on Antimicrobial Resistance Professor Alan Johnson National Infection Service Public Health England A Risk Assessment of Antibiotic Pan-Drug Resistance in the UK:

More information

Highlights on Hong Kong Strategy and Action Plan on Antimicrobial Resistance ( ) (Action Plan)

Highlights on Hong Kong Strategy and Action Plan on Antimicrobial Resistance ( ) (Action Plan) 香港藥學會 The Pharmaceutical Society of Hong Kong Kowloon G.P.O. Box 73552, Yau Ma Tei, Kowloon, Hong Kong Society s Fax: (852) 2376-3091 E-mail: pharmacist@pshk.hk Websites: http://pshk.hk Highlights on Hong

More information

WHO's View on IVDs for Addressing AMR

WHO's View on IVDs for Addressing AMR WHO's View on IVDs for Addressing AMR Francis Moussy, Ph.D. Lead for AMR Diagnostics Secretary, SAGE IVD 19 June 2017 1 World Health Assembly 2015 the global action plan sets out five strategic objectives:

More information

NAP on AMR: Singapore

NAP on AMR: Singapore FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14

More information

One Health, One Purpose:

One Health, One Purpose: One Health, One Purpose: Elanco s Antibiotic Stewardship Progress Report Del Holzer Sept. 28, 2016 One Year. One Purpose. One Health. Participation in the White House Summit on Antibiotic Stewardship Exceeding

More information

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov

More information

FDA Antibiotic Resistance Strategy

FDA Antibiotic Resistance Strategy FDA Antibiotic Resistance Strategy NIAA Antimicrobial Use and Resistance Symposium November 14, 2014 William T. Flynn, DVM, MS Center for Veterinary Medicine (CVM) U.S. Food and Drug Administration (FDA)

More information

Washington, DC Washington, DC Washington, DC Washington, DC 20515

Washington, DC Washington, DC Washington, DC Washington, DC 20515 November 20, 2017 The Honorable Thad Cochran The Honorable Patrick Leahy Chair Vice Chair United States Senate United States Senate Washington, DC 20510 Washington, DC 20510 The Honorable Rodney Frelinghuysen

More information

IFMSA Policy Proposal Antimicrobial Resistance

IFMSA Policy Proposal Antimicrobial Resistance IFMSA Policy Proposal Antimicrobial Resistance Proposed by Team of Officials Presented to the IFMSA General Assembly March Meeting 2017 in Arusha, Tanzania Policy Statement Introduction Antimicrobial resistance

More information

Interdisciplinary Communication in Antimicrobial Stewardship. Jennifer Liao, PharmD September 29, 2017 Patient Safety Academy

Interdisciplinary Communication in Antimicrobial Stewardship. Jennifer Liao, PharmD September 29, 2017 Patient Safety Academy Interdisciplinary Communication in Antimicrobial Stewardship Jennifer Liao, PharmD September 29, 2017 Patient Safety Academy Objectives 1. Define antimicrobial stewardship (AMS) teams across various settings

More information

Quality and Safety Committee

Quality and Safety Committee SUMMARY REPORT Quality and Safety Committee ABM University Health Board Meeting On 20 TH OCTOBER 2016 Subject Prepared by Approved & Presented by Purpose Big Fight Campaign AGENDA ITEM: 2.2 Debra Woolley

More information

The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals

The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals #209 The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals U.S. Department of Health and Human Services Food and Drug Administration Center for Veterinary Medicine June

More information

The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach

The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach Prese ted at the Workshop o Natio al A tio Plan on Antimicrobial Resistance for Developing Countries Focusing on Resistance

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required

More information

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health

More information

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018 7 December 2017 Committee for Medicinal Products for Veterinary Use (CVMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018 Chairpersons Chair: D. Murphy Status Adopted in December

More information

How to get senior hospital and clinical engagement

How to get senior hospital and clinical engagement How to get senior hospital and clinical engagement Professor Alison Holmes Professor of Infectious Diseases Director, NIHR Health Protection Research Unit: HCAI and AMR Engagement through Organisational

More information

Current Regulatory Landscape in Antibiotic Stewardship

Current Regulatory Landscape in Antibiotic Stewardship Current Regulatory Landscape in Antibiotic Stewardship Elizabeth Dodds Ashley, PharmD, MHS March 4, 2014 CDC Vital Signs Report 2 1 Core Elements of Stewardship Accountability Drug expertise Appointing

More information

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017) OIE Regional Commission for Europe Regional Work Plan Framework 2017-2020 Version adopted during the 85 th OIE General Session (Paris, May 2017) Chapter 1 - Regional Directions 1.1. Introduction The slogan

More information

Update on CDC Antibiotic Stewardship Activities

Update on CDC Antibiotic Stewardship Activities National Center for Emerging and Zoonotic Infectious Diseases Update on CDC Antibiotic Stewardship Activities CAPT Lauri Hicks, DO CAPT Arjun Srinivasan, MD Division of Healthcare Quality Promotion National

More information

WHO perspective on antimicrobial resistance

WHO perspective on antimicrobial resistance WHO perspective on antimicrobial resistance Bernadette Abela-Ridder, DVM, MSc, PhD Global Foodborne Infections Network (GFN) Coordinator Department of Food Safety and Zoonoses (FOS) 1 Overview of presentation

More information

Joint Statement on Antimicrobial Resistance

Joint Statement on Antimicrobial Resistance Joint Statement on Antimicrobial Resistance The UK Faculty of Public Health (FPH), the Royal College of Physicians (RCP), the Royal Pharmaceutical Society (RPS), the Royal College of Nursing (RCN) and

More information

GARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters

GARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters GARP ACTIVITIES IN KENYA Sam Kariuki and Cara Winters GARP-Kenya Situation Analysis Status of Conditions Related to Antibiotic Resistance 2010 Report Organization I. Health System Overview and Disease

More information

of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014

of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014 of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014 2 12 th Conference of the OIE Regional Commission for the Middle East Amman (Jordan),

More information

Antimicrobial Stewardship. October 2012

Antimicrobial Stewardship. October 2012 Antimicrobial Stewardship October 2012 Rising Antimicrobial Resistance Methicillin resistant staphylococcus aureus (MRSA) Vancomycin resistant enterococci (VRE) MDR and extremely drug resistant (XDR TB)

More information

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting COUNCIL OF THE EUROPEAN UNION Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting Luxembourg, 10 June 2008 The Council adopted

More information

COPING WITH ANTIMICROBIAL RESISTANCE

COPING WITH ANTIMICROBIAL RESISTANCE JANUARY 2018 COPING WITH ANTIMICROBIAL RESISTANCE REPORT 2 Friends of Europe January 2018 This is truly a global problem that can only be addressed by working together across the planet Tamsin Rose Senior

More information

Antimicrobial Stewardship. Where are we now and where do we need to go?

Antimicrobial Stewardship. Where are we now and where do we need to go? Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR 2017 @SPC2016Cork Antimicrobial Stewardship. Where are we now and where do we need to go? Frank O Riordan Antimicrobial pharmacist,

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Background Why Antimicrobial Stewardship 30-50% of antibiotic use in hospitals are unnecessary or inappropriate Appropriate antimicrobial use is a medication-safety and patient-safety

More information

Canadian Institutes of Health Research and Merck Canada November 17-18, 2016 Toronto, Canada

Canadian Institutes of Health Research and Merck Canada November 17-18, 2016 Toronto, Canada MULTI-STAKEHOLDER ANTIMICROBIAL STEWARDSHIP EXPERT FORUM Canadian Institutes of Health Research and Merck Canada November 17-18, 2016 Toronto, Canada Workshop Report At the Canadian Institutes of Health

More information

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8 Table Of Content Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8 Conference... 8 Coordinator, Leader contact and partners... 9 Outputs... 10 Final report...

More information

The Honorable Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention 1600 Clifton Rd, MS D-14 Atlanta, GA 30333

The Honorable Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention 1600 Clifton Rd, MS D-14 Atlanta, GA 30333 The Center for a Livable Future June 29, 2010 The Honorable Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention 1600 Clifton Rd, MS D-14 Atlanta, GA 30333 The Honorable Anthony

More information

Geriatric Mental Health Partnership

Geriatric Mental Health Partnership Geriatric Mental Health Partnership September 8, 2017 First, let s test your knowledge about antibiotics http://www.cdc.gov/getsmart/community/about/quiz.html 2 Get Smart Antibiotics Quiz Antibiotics fight

More information

Antimicrobial Resistance Tackling the Gap in R&D Resources with Pull Incentives

Antimicrobial Resistance Tackling the Gap in R&D Resources with Pull Incentives System Initiative on Shaping the Future of Health and Healthcare Antimicrobial Resistance Tackling the Gap in R&D Resources with Pull Incentives In collaboration with Wellcome Geneva, Switzerland, May

More information

RxPress. May/Jun Vol 16 No 3. The White House Releases Plan to Combat Antibiotic-Resistant Bacteria

RxPress. May/Jun Vol 16 No 3. The White House Releases Plan to Combat Antibiotic-Resistant Bacteria May/Jun 2015 Vol 16 No 3 RxPress TABLE OF CONTENTS The White House Releases Plan to Combat Antibiotic-Resistant Bacteria 1-2 FDA Requests New Data on Health Care Antiseptics 2-4 Penicillin Allergies and

More information

TEXTS ADOPTED Provisional edition. P8_TA-PROV(2018)0429 Animal welfare, antimicrobial use and the environmental impact of industrial broiler farming

TEXTS ADOPTED Provisional edition. P8_TA-PROV(2018)0429 Animal welfare, antimicrobial use and the environmental impact of industrial broiler farming European Parliament 204-209 TEXTS ADOPTED Provisional edition P8_TA-PROV(208)0429 Animal welfare, antimicrobial use and the environmental impact of industrial broiler farming European Parliament resolution

More information

Speaking notes submitted by Dr. Duane Landals. on behalf of the Canadian Veterinary Medical Association (CVMA)

Speaking notes submitted by Dr. Duane Landals. on behalf of the Canadian Veterinary Medical Association (CVMA) 339, rue Booth Street Ottawa (Ontario) K1R 7K1 t (800) 567-2862 f (613) 236-9681 admin@cvma-acmv.org Speaking notes submitted by Dr. Duane Landals on behalf of the Canadian Veterinary Medical Association

More information

Information note regarding the Danish and EU restrictions of non-therapeutical use of antibiotics for growth promotion

Information note regarding the Danish and EU restrictions of non-therapeutical use of antibiotics for growth promotion 12.08.2009 Information note regarding the Danish and EU restrictions of non-therapeutical use of antibiotics for growth promotion Denmark is a major animal food producer in Europe, and the worlds largest

More information